[Clinical observation of CD19-TANK cells in the treatment of relapsed/refractory B-cell lymphoma].
Zhonghua Xue Ye Xue Za Zhi
; 43(2): 153-156, 2022 02 14.
Article
in Zh
| MEDLINE
| ID: mdl-35381678
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, B-Cell
/
Receptors, Chimeric Antigen
Limits:
Humans
Language:
Zh
Journal:
Zhonghua Xue Ye Xue Za Zhi
Year:
2022
Document type:
Article
Affiliation country:
China
Publication country:
CHINA
/
CN
/
REPUBLIC OF CHINA